Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Expectancy Effects in Psychedelic Trials
Balázs Szigeti, Boris D. Heifets
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2024) Vol. 9, Iss. 5, pp. 512-521
Closed Access | Times Cited: 21

Showing 21 citing articles:

Psychedelics in Psychiatry: Oh, What A Trip!
Gregory A. Fonzo, Charles B. Nemeroff, Ned H. Kalin
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 1-5
Closed Access | Times Cited: 1
In the new era of psychedelic assisted therapy: A systematic review of study methodology in randomized controlled trials
Paul Soliman, Dallece E. Curley, Christy Capone, et al.
Psychopharmacology (2024) Vol. 241, Iss. 6, pp. 1101-1110
Closed Access | Times Cited: 6
Clinical and preclinical evidence of psilocybin as antidepressant. A narrative review
I. Erkizia-Santamaría, Igor Horrillo, J. Javier Meana, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111249-111249
Closed Access
Modifying Informed Consent to Help Address Functional Unmasking in Psychedelic Clinical Trials
Michelle Matvey, D. Parker Kelley, Ellen Bradley, et al.
JAMA Psychiatry (2025) Vol. 82, Iss. 3, pp. 311-311
Closed Access
Embracing Epistemic Humility: Rethinking Psychedelic Exceptionalism Through Diverse Perspectives
Jarrel De Matas, Amy L. McGuire, Hasan Yasin
The American Journal of Bioethics (2025) Vol. 25, Iss. 1, pp. 98-100
Closed Access
A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research
David B. Yaden, Marianna Graziosi, Anna Owen, et al.
Psychedelic Medicine (2025)
Closed Access
Psychedelics and Suicide-Related Outcomes: A Systematic Review
Shakila Meshkat, Taha Malik, Richard J. Zeifman, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 5, pp. 1416-1416
Open Access
Expectancy Effects, Failure of Blinding Integrity, and Placebo Response in Trials of Treatments for Psychiatric Disorders
Nathan T. M. Huneke, Guilherme Fusetto Veronesi, Matthew Garner, et al.
JAMA Psychiatry (2025)
Closed Access
Psychedelic Use and Behavioral Addictions
Trey Brasher, David S. Rosen, Marcello Spinella
Journal of Psychoactive Drugs (2025), pp. 1-14
Closed Access
«Psychedelics, OCD and Related Disorders: Setting Methodological Strategies for Future Studies»
Rodolfo Leuzzi, Giovanni Tardivo, Luca Pellegrini, et al.
Journal of Obsessive-Compulsive and Related Disorders (2025), pp. 100951-100951
Closed Access
Classic Psychedelics for the Treatment of Depression: Potential Benefits and Challenges
Sharmin Ghaznavi, Steffen Richter
Drugs (2025)
Closed Access
Motivation and retrospective appraisal of psychedelic study participation: a qualitative study in healthy volunteers
Laura Ley, Matthias E. Liechti, A. Becker, et al.
Psychopharmacology (2025)
Open Access
The relationship between blinding integrity and medication efficacy in randomised‐controlled trials in patients with anxiety disorders: A systematic review and meta‐analysis
Ruqayyah Haq, Laura Molteni, Nathan T. M. Huneke
Acta Psychiatrica Scandinavica (2024) Vol. 150, Iss. 4, pp. 187-197
Open Access | Times Cited: 2
The Relationship Between Blinding Integrity and Treatment Efficacy in Randomised-Controlled Trials in Patients with Anxiety Disorders: A Systematic Review and Meta-Analysis
Ruqayyah Haq, Laura Molteni, Nathan T. M. Huneke
(2024)
Open Access | Times Cited: 1
The psychedelic, DOI, increases dopamine release in nucleus accumbens to predictable rewards and reward cues
David Martin, Á.V. Delgado, Donna J. Calu
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Psychedelics in Medicine: Can Evidence Keep Up With Enthusiasm?
Harriet de Wit, Friederike Holze, Katrin H. Preller
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2024) Vol. 9, Iss. 5, pp. 460-461
Closed Access
Current Trends in Psychedelic Science: Integrating Modified Lysergic Acid Derivatives and Psilocybin in Modern Medicine
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 9, pp. 1443-1445
Open Access
Treatment Expectancies and Psilocybin vs Escitalopram for Depression
Ethan G. Dutcher, Andrew D. Krystal
JAMA Psychiatry (2024) Vol. 82, Iss. 3, pp. 321-321
Closed Access
Psychedelic-augmented psychotherapy for overcoming traumatic dissociation: A review of neuroscientific and phenomenological evidence
Ansgar Rougemont-Bücking, Florence Guenot, Virginie Salamin, et al.
European Journal of Trauma & Dissociation (2024) Vol. 8, Iss. 3, pp. 100431-100431
Open Access
The way of O: phenomenology of psychedelic use and the path to ultimate reality
Christopher W. T. Miller
Psychodynamic Practice (2024), pp. 1-20
Closed Access
"Vine of the Soul": The Potential of Ayahuasca for Reducing Depression, Anxiety, and Stress among Ceremony Participants and the Role of Rumination
Banan Ramarushton
(2024)
Open Access
Effects of psychedelic, DOI, on nucleus accumbens dopamine signaling to predictable rewards and cues in rats
David Martin, Angel M. Delgado, Donna J. Calu
Neuropsychopharmacology (2024) Vol. 49, Iss. 12, pp. 1925-1933
Closed Access
The association between study design and antidepressant effects in psychedelic-assisted therapy: A meta-analysis
Jia-Ru Li, Kuo-Tung Chiang, Yu‐Chen Kao, et al.
Journal of Affective Disorders (2024) Vol. 369, pp. 421-428
Closed Access
Page 1

Scroll to top